CRISPR THERAPEUTICS AG (CRSP) Net margin 2016–2025
CRISPR THERAPEUTICS AG (CRSP) net profit margin by fiscal year — reported net income divided by reported revenue.
-16569.8%FY2025 · since FY2016: -448.8% → -16569.8%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -16569.8% | -15588.2 pp |
| FY2024 | -981.5% | -940.2 pp |
| FY2023 | -41.4% | +54230.3 pp |
| FY2022 | -54271.7% | -54313.0 pp |
| FY2021 | 41.3% | +48562.1 pp |
| FY2020 | -48520.9% | -48543.9 pp |
| FY2019 | 23.1% | +5304.2 pp |
| FY2018 | -5281.1% | -5114.3 pp |
| FY2017 | -166.7% | +282.1 pp |
| FY2016 | -448.8% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice